BRACAnalysis Is a test for Hereditary Breast and Ovarian Cancer syndrome (HBOC) which is performed with a simple blood test or oral rinse sample.. The test identifies patients who have BRCA1 or BRCA2 mutations. BRCA mutations are responsible for the majority of hereditary breast and ovarian cancers. People with a mutation in either the BRCA1 or BRCA2 gene have risks of up to 87% for developing breast cancer and up to 44% for developing ovarian cancer by age 70. Knowing the results can help to determine who is a candidate for preventative treatment and extra surveillance.
Benefits of BRACAnalysis Testing
The results of the BRACAnalysis test enable us to create personalized management plans. BRACAnalysis will allow us to:
Offer appropriate surveillance and interventions
Significantly improve outcomes and reduce medical impact through earlier diagnosis and treatment of cancer, should it develop
Avoid unnecessary interventions for family members who do not test positive for the mutation if it is known to be in the family
For mutation carriers, the following medical management options may help reduce the risk of developing cancer, delay the onset of cancer, or allow cancer to be detected at an earlier, more treatable stage: